The Cure Alzheimer’s Fund recently announced that it has added three new members, Dr. Ben Barres, Dr. Bart De Strooper and Dr. Nancy Ip, to its Research Consortium.
Barres serves at Stanford University School of Medicine as the chair of the Department of Neurobiology.
De Strooper works as the director of the Center for Biology of Disease at VIB, which is the Flemish Institute for Biotechnology. He is also a professor at the Institute for Neurology, London and KU.
Ip works at the Hong Kong University of Science and Technology, where she is the dean of science.
"We are very fortunate that Ben, Bart and Nancy have agreed to join Cure Alzheimer's Fund's Research Consortium and believe their expertise and passion for ending this disease will help lead us to find effective treatments for Alzheimer's," Tim Armour, president and CEO of Cure Alzheimer's Fund, said. "With their vast knowledge and experience, they will be excellent additions to this exceptional group of scientists."
Cure Alzheimer’s Fund, a nonprofit, is committed to financing research that shows the most potential for preventing, slowing or reversing Alzheimer’s disease. Including new members means including new ideas to help Alzheimer’s patients around the world.
"I have had the privilege of working with Ben, Bart and Nancy, and their research has provided significant contributions to our understanding of Alzheimer's disease," Dr. Rudy Tanzi, chair of the Cure Alzheimer's Fund Research Consortium, said. "The consortium is an important place for researchers to share new insights into this disease, and I know that Ben, Bart and Nancy will add to our ability to advance research. I look forward to the benefit they will bring to Cure Alzheimer's Fund in their new capacity as members of our distinguished Research Consortium."
